1. Home
  2.  » 
  3. Events
  4.  » PBSS – Antibody-Drug Conjugates: Discovery to Development
PBSS – Antibody-Drug Conjugates: Discovery to Development

FEATURED SPEAKER

 


Penelope Drake

Head of R&D, Bioconjugates, Catalent

 

 

 

Session Title: Catalent’s SMARTag® Technology: Precision-Based ADC Design
Session Time: 10:55AM – 11:05AM PT
Abstract: Catalent’s SMARTag® technology platform offers ADC and biologics developers a one-step toolkit to develop optimized ADCs and bioconjugates. The SMARTag® technology enables site-specific, controlled drug-protein conjugation, and uses only naturally occurring modifications to proteins requiring minimal cell-line engineering.